Therefore, PKD1 down-regulation in prostate cancer further activates the Wnt/β-catenin signaling pathway by destabilizing the E-cadherin/β-catenin complex, which leads to increased amounts of β-catenin available for translocation to the nucleus. The gene discussed is CDH1; the disease is prostate cancer.